The effect of dietary red palm oil on the functional recovery of the ischaemic/reperfused isolated rat heart: the involvement of the PI3-Kinase signaling pathway by Engelbrecht, Anna-Mart et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Lipids in Health and Disease
Open Access Research
The effect of dietary red palm oil on the functional recovery of the 
ischaemic/reperfused isolated rat heart: the involvement of the 
PI3-Kinase signaling pathway
Anna-Mart Engelbrecht1, Louise Odendaal1, Eugene F Du Toit2, 
Kristina Kupai3, Tamás Csont3, Peter Ferdinandy3 and Jacques van Rooyen*4
Address: 1Department of Physiological Sciences, University of Stellenbosch, Stellenbosch, 7600, South Africa, 2Department of Medical Physiology, 
University of Stellenbosch, Stellenbosch, 7600, South Africa, 3Cardiovascular Research Group, Department of Biochemistry, University of Szeged 
and Pharmahungary™ Group, Szeged, Hungary and 4Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, 7535, 
Bellville, South Africa
Email: Anna-Mart Engelbrecht - ame@sun.ac.za; Louise Odendaal - odendaall@cput.ac.za; Eugene F Du Toit - efdt@sun.ac.za; 
Kristina Kupai - krisztina.kupai@pharmahungary.com; Tamás Csont - tamas.csont@pharmahungary.com; 
Peter Ferdinandy - peter.ferdinandy@pharmahungary.com; Jacques van Rooyen* - vanrooyenj@cput.ac.za
* Corresponding author    
Abstract
We have previously shown that dietary red palm oil (RPO) supplementation improves functional
recovery in hearts subjected to ischaemia/reperfusion-induced injury. Unfortunately, the cellular
and molecular mechanisms responsible for this phenomenon are still poorly understood and no
knowledge exists regarding the effects of RPO supplementation on the phosphoinositide 3-kinase
(PI3-K) signaling pathway and apoptosis during ischaemia/reperfusion injury. Therefore, the aims of
the present study were three fold: (i) to establish the effect of RPO on the functional recovery of
the heart after ischaemia/reperfuion injury; (ii) to determine the effect of the PI3-K pathway in
RPO-induced protection with the aid of an inhibitor (wortmannin); and (iii) to evaluate apoptosis
in our model. Wistar rats were fed a standard rat chow control diet or a control diet plus 7 g RPO/
kg for six weeks. Hearts were excised and mounted on a Langendorff perfusion apparatus.
Mechanical function was measured after a 25 min period of total global ischaemia followed by 30
minutes of reperfusion. Hearts subjected to the same conditions were freeze-clamped for
biochemical analysis at 10 min during reperfusion to determine the involvement of the PI3-Kinase
signaling pathway and apoptosis in our model. Dietary RPO supplementation significantly increased
% rate pressure product recovery during reperfusion (71.0 ± 6.3% in control vs 92.36 ± 4.489% in
RPO; p < 0.05). The % rate pressure product recovery was significantly reduced when wortmannin
was added during perfusion (92.36 ± 4.489% in the RPO group vs 75.21 ± 5.26% in RPO + Wm).
RPO + Wm also significantly attenuated PI3-K induction compared with the RPO group (59.2 ± 2.8
pixels in RPO vs 37.9 ± 3.4 pixels in RPO + Wm). We have also demonstrated that PI3-K inhibition
induced PARP cleavage (marker of apoptosis) in the hearts during ischaemia/reperfusion injury and
that RPO supplementation counteracted this effect.
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Background
Cardiovascular disease is one of the major causes of death
in the Western world. It is believed to account for more
than 12 million deaths annually [1]. Although it was pre-
viously demonstrated that dietary RPO protects the heart
against ischemia/reperfusion-induced injury [2], the pre-
cise molecular mechanisms are still unclear.
RPO is a natural oil obtained from oil palm fruit (Elaeis
guineensis). It is high in palmitic acid (44%) and oleic acid
(40%) with natural fat-soluble tocopherol, tocotrienol
and carotonoids, which may act as antioixants. Despite
the high saturated fat content of RPO, several studies have
demonstrated that RPO is associated with better recovery
and protection of hearts submitted to ischaemia/reper-
fusion [2-4]. RPO-supplementation also caused differen-
tial phosphorylation of the MAPKs which were associated
with improved functional recovery and reduced apoptosis
[3,4]. This indicated that the improved physiological
function associated with RPO-supplementation, was due
to the cellular signaling effects of RPO, both through the
NO-cGMP pathway or the pro-survival Akt pathway.
These studies suggest that a combination of carotonoids,
lycopene, pro-vitamin E and fatty acids provide more pro-
tections than one individual component [5-7].
The serine/threonine protein kinase, protein kinase B (a
member of the PI3-K pathway), is a crucial regulator of
widely divergent cellular processes including apoptosis
(programmed cell death), cell proliferation, differentia-
tion and metabolism [8,9]. Several researchers have
reported that activation of PI3-K and Akt play an impor-
tant role in promoting cardiomyocyte survival and func-
tion in models of cardiac injury [10,11]. Therefore,
disruption of normal PI3-K signaling pathway during
ischaemia/reperfusion-induced injury should therefore be
considered as a potential target for therapy.
However, as far as we know, no evidence exits for the
interaction between RPO and the PI3-K signaling pathway
during reperfusion. In order to assess the possible mecha-
nisms of protection, the isolated perfused rat heart model
with the aid of a PI3-K inhibitor, wortmannin (Wn) was
used to assess signaling proteins after RPO-supplementa-
tion.
Results
Percentage Rate Pressure Product Recovery (% RPP) 
(Figure 1)
RPO-supplementation caused an increase in % RPP recov-
ery at 10 min during reperfusion when compared with the
control group (65.5 ± 6.3% in control vs 93.5 ± 5.2% in
RPO; p < 0.05) confirming results in previous similar
studies. Our results also indicate that C+Wn had an
increased % RPP at the same time point, when compared
to the control group (65.5 ± 6.3% in control vs 95.0 ±
8.0% in C+Wn; p < 0.05). After 30 minutes of reperfusion,
the % RPP in the RPO group was still significant higher
compared to the control group (71.03 ± 5.82% in control
vs 92.36 ± 4.48% in RPO; p < 0.05). However, at this time
point, there was also a significant difference between the
RPO and the RPO+Wn groups (92.36 ± 4.48% in RPO vs
75.21 ± 5.23% in RPO+Wn; p < 0.05). Table 1 shows the
pre-ischaemic values of heart rate, developed pressure,
rate pressure product and coronary flow in control and
red palm oil groups. These values were used to calculate
the % RPP.
The effect of RPO and wortmannin (Wn) on the regulatory 
subunit (p85) of PI3-Kinase (Figure 2)
RPO+Wn significantly decreased PI3-K (p85) activity
compared to RPO alone (37.9 ± 3.4 pixels vs 59.2 ± 1.8
pixels; p < 0.05).
The effect of RPO and wortmannin (Wn) on PKB/Akt 
(Ser473) phosphorylation (Figure 3)
Wortmannin administration during perfusion caused a
significant decrease in PKB/Akt (Ser473) phosphorylation
compared to the control group (33.2 ± 10.7 pixels for
C+Wn vs 106.4 ± 7.8 pixels for C; p < 0.05). RPO counter-
acted this decrease in phosphorylation when the RPO-fed
animals received wortmannin during perfusion (33.2 ±
10.7 pixels in C+Wn vs 75.87 ± 10.3 pixels in RPO+Wn; p
< 0.05).
The effect of RPO and wortmannin (Wn) on FKHR (Ser256) 
phosphorylation (Figure 4)
There was a significant decrease in FKHR phosphorylation
in the RPO+Wn group when compared with the RPO
group (130.9 ± 3.5 pixels vs 73.00 ± 14.1 pixels; p < 0.05).
The effect of RPO and wortmannin (Wn) on Caspase-3 
cleavage (Figure 5)
Wortmannin significantly increased caspase-3 cleavage
compared with the control group (38.21 ± 4.14 pixels vs
56.27 ± 3.63 pixels; p < 0.05). Interestingly, wortmannin
also caused a significant increase in caspase-3 cleavage in
the RPO group compared with the RPO control group
(26.75 ± 2.6 pixels vs 59.79 ± 2.1 pixels; p < 0.05).
The effect of RPO and wortmannin (Wn) on PARP 
cleavage (Figure 6)
There was an increase in cleaved PARP in the control+Wn
group when compared to the control group (42.12 ± 7.0
pixels vs 98.9 ± 9.3 pixels; p < 0.05. PARP cleavage was sig-
nificantly reduced in the RPO+Wn group compared with
the control wortmannin group (98.9 ± 9.3 vs 50.23 ± 6.9
pixels; p < 0.05.Lipids in Health and Disease 2009, 8:18 http://www.lipidworld.com/content/8/1/18
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Discussion
We have demonstrated that dietary RPO supplementation
offered significant protection against ischemia/reper-
fusion-induced injury in the isolated perfused working
heart as reflected by improving functional recovery after
10 and 30 minutes of reperfusion. Furthermore, we have
demonstrated for the first time that this effect of RPO was
significantly attenuated when these hearts were perfused
with the PI3-Kinase inhibitor, wortmannin. Therefore, we
can conclude that the RPO-induced protection of the
heart during ischemia/reperfusion-induced injury is, at
least in part, mediated by the PI3-kinase pathway.
In response to ischemia/reperfusion-induced injury, cells
activate various signal transduction pathways which
either may be harmful or allow adaptation to this stressful
environment. There is an increasing body of evidence
showing that PKB/Akt may represent a nodal point to
coordinate growth factor signaling in the early phase of
ischemia/reperfusion-induced injury in the heart [12,13].
However, no knowledge exists about the possible involve-
ment of the PI3-K/Akt pathway in RPO-induced protec-
tion during ischemia/reperfusion injury in the heart.
Therefore, another aim of this study was to determine
whether PI3-Kinase inhibition induced changes in protein
Rate Pressure Product Recovery (%) Figure 1
Rate Pressure Product Recovery (%). The effect of RPO-supplementation and Wortmannin administration on RPP recov-
ery during reperfusion (n = 7–10 per group) (mean +/- SEM), (* p < 0.05 for indicated groups).
0
20
40
60
80
100
120
5 min 10 min 30 min
Time (Reperfusion)
%
 
R
P
P
 
r
e
c
o
v
e
r
y
C (n=7)
RPO (n=8)
C+Wn (n=7)
RPO+Wn (n=10)
*
*
* *
Table 1: Pre-ischaemic values of heart rate, developed pressure, rate pressure product and coronary flow in control and red palm oil 
groups
Heart Rate (beats/min LVDev P (mmHg) Coronary Flow (ml/min) Rate Pressure Product (HR X LVDevP)
Control 296.6 ± 13.5 92.4 ± 3.9 16.7 ± 1.8 26314 ± 1973
Control + W 290.0 ± 10.8 75.1 ± 5.7& 12.5 ± 2.3 21778 ± 1940
RPO 312.0 ± 10.7 75.7 ± 3.5$ 17.2 ± 1.0 23630 ± 1330
RPO + W 276.2 ± 13.9 67.2 ± 2.4# 12.2 ± 1.5 19104 ± 1389*Lipids in Health and Disease 2009, 8:18 http://www.lipidworld.com/content/8/1/18
Page 4 of 8
(page number not for citation purposes)
phosphorylation and apoptosis in hearts subjected to
ischemia/reperfusion injury of animals which received
dietary RPO supplementation.
Upon growth factor activation of receptor tyrosine
kinases, PI3-K is recruited to the receptor in the plasma
membrane and phosphorylates phosphatidylinositol-4,5-
bisphosphate (PIP2) on the 3-OH group, generating phos-
phatidylinositol-3,4,5-trisphosphate (PIP3). PI3-kinase is
considered one of the intracellular signals responsible for
the transmission of anti-apoptotic signals for controlling
cell survival. Over expression of PI3-kinase in cells has
been shown to cause a significant increase in survival of
cells exposed to ionizing radiation [14]. Kennedy and co-
workers also reported that inhibition of PI3-K causes an
The effect of RPO-supplementation and Wortmannin admin- istration on PI3-K (p85) activity in hearts subjected to ischae- mia/reperfusion (n = 3–7 per group) (mean +/- SEM), (* p <  0.05 for indicated groups) Figure 2
The effect of RPO-supplementation and Wortman-
nin administration on PI3-K (p85) activity in hearts 
subjected to ischaemia/reperfusion (n = 3–7 per 
group) (mean +/- SEM), (* p < 0.05 for indicated 
groups).
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p85 subunit of PI3-K 
The effect of RPO-supplementation and Wortmannin admin- istration on PKB/Akt (Ser473) phosphorylation in hearts sub- jected to ischaemia/reperfusion (n = 3–7 per group) (mean ±  SEM) (* p < 0.05 for indicated groups) Figure 3
The effect of RPO-supplementation and Wortman-
nin administration on PKB/Akt (Ser473) phosphor-
ylation in hearts subjected to ischaemia/reperfusion 
(n = 3–7 per group) (mean ± SEM) (* p < 0.05 for indi-
cated groups).
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The effect exerted by RPO-supplementation and Wortman- nin administration on FKHR phosphorylation in hearts sub- jected to ischaemia/reperfusion (n = 3–7 per group) (mean ±  SEM) (* p < 0.05 for indicated groups) Figure 4
The effect exerted by RPO-supplementation and 
Wortmannin administration on FKHR phosphoryla-
tion in hearts subjected to ischaemia/reperfusion (n = 
3–7 per group) (mean ± SEM) (* p < 0.05 for indicated 
groups).
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The effect exerted by RPO-supplementation and Wn admin- istration on the cleavage of caspase-3 in hearts subjected to  ischaemia/reperfusion (n = 3–7 per group) (mean ± SEM) (* p  < 0.05 for indicated groups) Figure 5
The effect exerted by RPO-supplementation and Wn 
administration on the cleavage of caspase-3 in hearts 
subjected to ischaemia/reperfusion (n = 3–7 per 
group) (mean ± SEM) (* p < 0.05 for indicated 
groups).
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Cleaved caspase-3 Lipids in Health and Disease 2009, 8:18 http://www.lipidworld.com/content/8/1/18
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increase in apoptosis and a decrease in cell survival [15].
PI3-kinases are composed of a catalytic subunit (p110)
and a regulatory subunit (p85). PI3-kinase inhibition
with wortmannin significantly reduced the regulatory
subunit (p85) when compared with the RPO control
group. This decrease in PI3-K activity also correlates with
reduced function after 30 minutes of perfusion in the iso-
lated hearts in the RPO+Wn group compared to the RPO
control group. Results in previous studies (2, 3, 4) showed
that the signaling pathways were activated early in reper-
fusion whilst the true functional effect of these biochemi-
cal changes were only observed at later time points.
PKB/Akt is one of the most important targets of PI3-K
because it phosphorylates and regulates a wide variety of
proteins implicated in cell survival/death decisions. Acti-
vation of PKB requires binding to PIP3 via the pleckstrin
homology domain and phosphorylation of Thr308 in the
activation loop as well as phosphorylation of Ser473
within the carboxy-terminal [16]. The present results
reveal that wormannin significantly reduced PKB (Ser473)
phosphorylation when compared to the control group
and that this reduction was partly counteracted in the
RPO+Wn group. It was previously demonstrated (3) that
PKB could play a role in RPO protection. In the current
study the protective effect of RPO was abolished in the
RPO+Wn group at 30 minutes of reperfusion. This indi-
cates that PI3-K pathway may have had an effect on the
RPO-induced protection. Although there was no signifi-
cant decrease in PI3-K in the RPO group, PI-3K was signif-
icantly reduced in the RPO+Wn group.
Although PKB promotes cell survival, the mechanisms
involved have only recently begun to emerge. One means
by which PKB may promote cell survival is by directly
phosphorylating transcription factors that control the
expression of pro- and anti-apoptotic genes. PKB appears
to both negatively regulate factors that promote the
expression of death genes and positively regulate factors
that induce survival genes [17,18]. An example is the fam-
ily of forkhead transcription factors (FKHR). All the mem-
bers of the FKHR family contain a PKB phosphorylation
sequence which can be effectively phosphorylated by PKB
in vitro [19,20]. Phosphorylation of FKHR by PKB alters its
subcellular location. FKHR phosphorylation was signifi-
cantly inhibited when RPO+Wn was compared to the
RPO group. This leads to forkhead proteins residing pre-
dominantly in the nucleus where they are able to promote
transcription of pro-apoptotic genes such as Fas-L and Bim
through specific DNA elements in their promotor regions
[21,22]. This result also correlates with the attenuation in
function recovery in the RPO+Wn group compared to the
control RPO group. Phosphorylation of FKHR by PKB
leads to the export of FKHR from the nucleus and its accu-
mulation and sequestration by 14-3-3 proteins in the
cytoplasm [22]; thus inhibiting apoptosis.
Another hallmark of the apoptotic pathway is the cleavage
of caspase-3. Wortmannin caused significant increases in
caspase-3 cleavage in the control and in the RPO group,
thereby promoting apoptosis in these groups. Further-
more, wortmannin also induced a significant increase in
PARP cleavage to its proteolyzed products, a phenome-
non that is well known to result from caspase-3 activation
[19,20]. Interestingly, this increase cleavage of PARP was
not observed in the RPO+Wn group. However, it is possi-
ble that an increase in this group may be seen if the reper-
fusion period is extended.
Currently there is no clear evidence that a single substance
in the red palm oil is responsible for the protection or
effect on the signaling pathways. Previous studies suggest
that a combination of carotonoids and vitamin E in the
presence of lycopene in a natural food supplement have a
far more potent anti-oxidative effect [5-7] than when con-
sumed in an isolated form.
Conclusion
The present study demonstrates that the beneficial effect
of RPO during ischemia/reperfusion-induced injury is
partially mediated by the PI3-kinase signaling pathway.
PI3-K inhibition attenuated functional recovery of the
hearts during reperfusion. This attenuation in functional
recovery when PI3-K was inhibited also correlated with
reduced PKB and FKHR phosphorylation. This, in turn,
leads to increased apoptosis as indicated by increased cas-
The cleavage of PARP in hearts subjected to ischaemia/reper- fusion that received RPO-supplementation and Wortmannin  administration (mean ± SEM) (n = 3–7 per group) (* p < 0.05  for indicated groups) Figure 6
The cleavage of PARP in hearts subjected to ischae-
mia/reperfusion that received RPO-supplementation 
and Wortmannin administration (mean ± SEM) (n = 
3–7 per group) (* p < 0.05 for indicated groups).
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pase-3 and PARP cleavage. The beneficial effect of RPO
during ischemia/reperfusion-induced injury is thus asso-
ciated with the PI3-K/PKB signaling pathway and thus
points towards this pathway as a potential therapeutic tar-
get. The effects of RPO on cardiac function should be fur-
ther characterized for the purpose of development as an
agent for the management of ischemic injury.
Methods
All animals received humane care in accordance with the
Principles of Laboratory Animal Care of the National Society of
Medical Research and the Guide for the Care and use of Lab-
oratory Animals of the National Academy of Sciences
(National Institutes of Health publications no. 80-23,
revised 1978).
Experimental Groups
Male Wistar groups were randomly divided into four
groups: two control groups receiving standard rat chow
and two experimental groups receiving standard rat chow
plus 2 ml RPO (Carotina Premium) for 4 weeks. The com-
position of Carotino Premium red palm oil (per 100 ml)
is given in Table 2. Red palm oil was mixed with one pellet
of the chow every morning. Rats were only fed the rest of
the daily rat chow allowance after they consumed the pel-
let with the red palm oil.
Heart Perfusion
Rats weighing 300–400 g were anaesthetized with sodium
pentobarbital, before hearts were rapidly excised and
briefly rinsed by immersion in ice-cold Krebs-Henseleit
buffer. Hearts were transferred to a Langendorff perfusion
apparatus and perfused with a Krebs-Henseleit buffer
equilibrated with 95% O2 and 5% CO2 at 37°C (118, 5
mM NaCl; 4.75 mM KCL; 1.2 mM MgCl ￿ 6 H2O; 1.36
mM CaCl2; 25, 0 mM NaHCO3; 1.2 mM KH2PO4; 11, 0
mM glucose). Pressure was kept constant at 100 cm H2O.
The aorta was cannulated and retrograde perfusion was
initiated. Hearts were kept in a water-jacketed chamber to
maintain temperature at 37°C. Immediately after cannu-
lation, excess tissue and the left atrium was removed. A
water-filled balloon (made from transparent sandwich
wrap), connected to a pressure transducer, was inserted
through the opening of the left atrium into the left ventri-
cle. The pressure transducer was connected to a Powerlab
system (ADInstruments Pty Ltd. Castle Hill, Australia) on
a computer. After insertion, the balloon was inflated to 2
mmHg, and the contraction force of the heart against the
balloon causes pressure on the fluid filled balloon. This
pressure is then registered on the Powerlab system. Thus,
systolic pressure, diastolic pressure and heart rate were
measured. The first 10 min of perfusion was used to stabi-
lize the heart.
Perfusion Protocol
The study was divided into two perfusion protocols. In the
first protocol, hearts were perfused for 10 min stabiliza-
tion, followed by 20 min, during which mechanical func-
tion was documented. Hearts were then subjected to 25
min of total gloabal ischaemia. After the ischaemic
period, hearts were reperfused for 30 min and mechanical
function was again documented. To reduce the incidence
of arrhythmias during reperfusion, a 2% lignocaine solu-
tion was used for the last min of pre-ischaemia perfusion
as well as the initial 3 min of reperfusion in all hearts. In
the second protocol, hearts were stabilized for 10 min and
perfused for 15 min, before being subjected to a wortman-
nin solution (100 nM) for 5 min pre-ischaemia. After the
25 min total global ischaemic period, hearts were reper-
fused for 3 min with the wortmannin solution, before
reverting to the drug-free Krebs-Henseleit buffer for the
rest of the 27 min reperfusion period. Functional and bio-
chemical measurements were taken.
Mechanical Function Parameters measured
Functional measurements were taken during pre-ischae-
mia (20 min perfusion) and at 5 min, 10 min and 30 min
into reperfusion. Heart rate and left ventricle developed
pressure (LVDevP) were measured. LVDevP was calcu-
lated as the difference between left ventricular systolic
(LVSP) and diastolic (LVDP) pressures. The rate pressure
product (RPP) was calculated as the product of heart rate
and LVDevP.
Biochemical Analysis
To assess myocardial biochemical function, hearts, from
all groups, were freeze clamped 10 min into reperfusion
with Wollenberger clamps precooled in liquid nitrogen.
Cardiac proteins were extracted with a lysis buffer contain-
ing: 20 mM Tris; 20 mM p-nitrophenylphosphate; 1 mM
EGTA; 50 mM NaF; 0.1 sodium orthovanadate; 1 mM
Table 2: The components of Carotino Premium red palm oil 
(per 100 ml)
Total fats 92 g
Monounsaturates 43 g
Polyunsaturates 12 g
Saturates 37 g
Trans fat 0 g
Cholesterol, Sodium 0 g
Protein, Carbohydrate, Dietary fibre 0 g
Natural Carotenes 46 mg
Natural Vitamin E 74 mg
Co-Enzyme Q10 4 mg
LVDevP = Left ventricular developed pressure; RPO = red palm oil; 
W = wortmanin
P < 0.05* RPO+W vs Control
# RPO+W vs Control
$RPO vs Control
&Control + W vs ControlLipids in Health and Disease 2009, 8:18 http://www.lipidworld.com/content/8/1/18
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phenylmethyl sulfonyl fluoride (PMSF); 1 mM dithiothre-
itol (DTT); 10 μg/ml aprotinin. The tissue lysates were
diluted in Laemmli sample buffer, boiled for 5 min and
60 μg protein was separated by 10% PAGE-SDS gel elec-
trophoresis. The lysate protein content was determined
using the Bradford technique [23]. The separated proteins
were transferred to a PVDF membrane (Immobilon P,
Millipore). These membranes were routinely stained with
Ponceau Red for visualization of proteins. Nonspesific
binding sites on the membranses were blocked with 5%
fat-free milk in Tris-buffered saline – 0.1% Tween 20
(TBST) and then incubated with the primary antibodies
that recognize PKB/Akt (Ser473 and Thr308) and total PKB/
Akt, PI3-K (p85), PDK1 (Ser241), FKHR (Ser256), GSK-3β
(Ser9), cleaved caspase-3 (Asp175), cleaved PARP (Asp214)
and PTEN (Ser380). Membranes were subsequently
washed with large volumes of TBST (5 × 5 min) and the
immobilized antibody conjugated with a diluted horse-
radish peroxidase-labaled secondary antibody (Amer-
sham, LIFE SCIENCE). After thorough washing with TBST,
membranes were covered with ECL detection reagents and
quickly exposed to an autoradiography film (Hyperfilm
ECL, RPN 2103) to detect light emission through a non-
radioactive method (ECL Western blotting). Films were
densitometrically analyzed (UN-SCAN-IT, Silkscience)
and phoshorylated protein values were corrected for
minor differences in protein loading, if required. Antibod-
ies were purchased from Cell Signalling Technology and
all other chemicals were obtained from Sigma (St Louis,
Missouri, USA).
Data analysis
Values are expressed as mean ± standard error of the mean
(SEM). Some functional values are presented as percent-
age change from the baseline values. Results were com-
pared by using a one-way ANOVA with a Bonferoni
Multiple Comparison as a post hoc test. P < 0.05 was con-
sidered as statistically significant.
Abbreviations
A: beta; C: control; cm: centimeter; CO2: carbon dioxide;
DTT: Dithiothreitol; FKHR: Forkhead transcription factor;
g: gram; LVDevP: Left ventricular developed pressure;
Min: minutes; ml: milliliter; mM: millimolar; O2: oxygen;
%: percentage; PMSF: Phenylmethyl sulfonyl fluoride;
PTEN: Phoshoinositide-lipid-3-phosphotase; PIP3: Phos-
phatidylinositol-3,4,5-trisphosphate; PDK-1: Phosphoi-
nositide-dependent kinase-1; PI-3K: Phosphatidylinositol
3-kinase; PARP: Poly(ADP-ribose) polymerase RPP: rate
pressure product; ROS: reactive oxygen species; RPO: red
palm oil; PKB/Akt: Serine/threonine protein kinase, pro-
tein kinase B or AKT; SEM: Standard error of the mean;
H2O: water; Wn: wortmannin.
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